Red blood cell (RBC) transfusion rates among US chronic dialysis patients during changes to Medicare end-stage renal disease (ESRD) reimbursement systems and erythropoiesis stimulating agent (ESA) labels

BACKGROUND: Several major ESRD-related regulatory and reimbursement changes were introduced in the United States in 2011. In several large, national datasets, these changes have been associated with decreases in erythropoiesis stimulating agent (ESA) utilization and hemoglobin concentrations in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappell, Katherine A, Shreay, Sanatan, Cao, Zhun, Varker, Helen V, Paoli, Carly J, Gitlin, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112651/
https://www.ncbi.nlm.nih.gov/pubmed/25015348
http://dx.doi.org/10.1186/1471-2369-15-116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112651/
https://www.ncbi.nlm.nih.gov/pubmed/25015348
http://dx.doi.org/10.1186/1471-2369-15-116

Ejemplares similares